期刊文献+

白藜芦醇苷对慢性低氧性肺动脉高压大鼠肺内突变型p53基因表达的影响 被引量:3

白藜芦醇苷对慢性低氧性肺动脉高压大鼠肺内突变型p53基因表达的影响
下载PDF
导出
摘要 目的研究白藜芦醇苷(PD)对慢性低氧性肺动脉高压(CHPH)大鼠肺内突变型p53基因表达的影响。方法将SD大鼠随机分为对照组、低氧组和低氧+PD治疗组。观察PD对CHPH大鼠平均肺动脉压(mPAP)、右心室肥厚指数[右室/左室+室间隔(R/L+S)]、肺血管形态学指标、突变型p53基因表达的影响。结果21d后,低氧组mPAP、R/(L+S)、肺血管管壁面积占血管总面积的百分比、管壁厚度占血管外径的百分比及突变型p53基因表达明显升高,肺血管管腔面积占血管总面积的百分比明显降低;低氧+PD组上述变化得到抑制或减轻。结论PD可有效降低肺动脉压,延缓大鼠CHPH进程,其机理可能与抑制突变型p53基因表达及细胞增殖,从而有效抑制肺血管重建有关。 Objective: To investigate the effects of polidatin on expression of p53 in chronic hypoxic rats. Methods: 30 healthy Spraque-Dawley male rats were randomly divided into normal control group, chronic hypoxic group and hypoxia plus polidatin treatment group. The model of rat chronic hypoxic pulmonary hypertension (CHPH) was made by intermittent isobaric hypoxia for 21 days. The indexs including mean pulmonary arterial pressure (mPAP), R/(L+S), vascular morphologic indexes of pulmonary and expression of p53 in pulmonary tissue of rats were measured. Results: 21 days after exposed to hypoxia,the mPAP, R/(L+ S), MT%, MA%, expression of p53 increased significantly. VA% decreased significantly. Pretreated with PD could attenuate the changes mentioned above. Conclusions : Pretreatment with PD can effectively prevent the formation of CHPH. It may be related to the inhibition of p53 which can enhance proliferation and decrease apoptosis, that contribute to postpone the development of pulmonary vascular remodeling.
出处 《山东医药》 CAS 北大核心 2006年第13期19-20,共2页 Shandong Medical Journal
基金 广东省自然科学基金项目(960761)
关键词 低氧 白藜芦醇苷 肺血管重建 基因 p53 肺动脉高压 hypoxia polidatin pulmonary vascular remodeling genes, p53
  • 相关文献

参考文献4

二级参考文献30

  • 1陈思锋,吴中立.体液和组织磷脂酶A_2简便快速测定法[J].第二军医大学学报,1989,10(3):254-256. 被引量:210
  • 2薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 3冉丕鑫,钟南山.生长因子、原癌基因与低氧性肺动脉高压[J].基础医学与临床,1996,16(1):1-5. 被引量:24
  • 4车东媛,熊密.肺血管构形重建的特征和形成机制[J].基础医学与临床,1996,16(1):17-20. 被引量:17
  • 5孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 6Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasisin health and disease. Pediatr Res. 2001,49(5):614 ~617
  • 7Semenza GL, Agani F, Feldser D, et al. Hypoxia, HIF-1, andthe pathophysiology of common human diseases. Adv Exp Med Biol, 2000,475 : 123 ~ 130
  • 8Jiang BH, Semenza GL,Bauer C, et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 1996, 271 (Cell Physiol. 40): C1172~C1180
  • 9Jiang BH , Zhen JZ, Leng SW, et al. Transactivation and inhibitory domins of hypoxia-inducible factor-1 alpha: modulation of transcriptional activity by oxygen tension. J Biol Chem. 1997, 272(31 ) :19253~19260
  • 10Salceda S, Caro J. hypoxia-inducible factor-1 alpha(HIF-1α) pro tein is rapidly degraded by the ubiqutin-proteasome system under nomoxic conditions: its stabilization by hypoxia depends upon re dox-induced changes. J Boil Chem. 1997,272: 22642~ 22647

共引文献171

同被引文献72

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部